durvalumab,tremelimumab
astrazeneca
[]
the #infinity trial: neoadjuvant durva/tremi in pts with dmmr g/gej cancers. very promising data in another dmmr population in the neoadjuvant setting! congrats #gi23 
Medical Oncologist, GI cancers @nki_nl neoadjuvant #immunotherapy #cancerresearch. Opinions my own